Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Safety and Quality of Life of Cancer Patients Treated by Autologous Immune Enhancement Therapy (AIET) in Vinmec International Hospitals

NCT05520372 is registered in ClinicalTrials.gov with Vinmec Research Institute of Stem Cell and Gene Technology as lead sponsor.

NCT NCT05520372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Safety and Quality of Life of Cancer Patients Treated by Autologous Immune Enhancement Therapy (AIET) in Vinmec International Hospitals
Lead sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2016
Completion date
December 30, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with cancer